Coronavirus and SARS-CoV-2 Pandemic Diseases

Main Article Content

Ayhan Güler
Ceren Başkan
Belgin Sırıken

Abstract

Coronaviruses which are a large family of viruses  lead to upper-respiratory diseases in the especially respiratory system and enteric, hepatic and neurological systems with different severity in human as well as a wide variety of animals.  Coronaviruses involved in four genera, and beta-CoVs are the most important group and the most highly pathogenic viruses against humans such as Severe Acute Respiratory Disease (SARS) -CoV-2. SARS-CoV-2 is the third quite pathogenic human coronavirus, and can pass through animals to human or human to human due to capable of cross the species barrier into the human populations. Up to 2 July, 2020, coronavirus cases are 10,720,755 and deaths number are 517,005. Many variety mammalians groups such as pigs, cows, chicken, dogs, cats and human are harbor for CoVs. Among them, especially bats are very important for harbor and enhance the change of interspecies transmission of the viruses. According to SARS-CoV-2 symptoms, it is change to asymptomatic forms to respiratory failure and systemic manifestations such as sepsis, septic shock and multiple organ dysfunctions syndrome. For SARS-CoV-2 inactivation way is by lipid solvents including 75% of ether, 80% of ethanol, 75% of isopropanol, chlorine containing disinfectant, peroxyacetic acid, and chloroform except for chlorhexidine, alkaline (pH˃ 12) or acidic (pH ˂3) conditions, formalin and glutaraldehyde treatments. It is taken community measures against SAR-CoV-2 to control the spread of infection and diseases. To SARS CoV-2, there has been no vaccine and specific anti-viral drugs so far. Therefore, public health measures are considered as an effective tool for community. For this aim, hand hygiene, use of mask, hospital environment, droplet, airborne and contact precautions, institutional safeguard and standard measures should be used.

Downloads

Download data is not yet available.

Article Details

How to Cite
GülerA., BaşkanC., & SırıkenB. (2020). Coronavirus and SARS-CoV-2 Pandemic Diseases. Medical Science and Discovery, 7(9), 617-624. https://doi.org/10.36472/msd.v7i9.421
Section
Review Article

References

1. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). 2020.https://www.ncbi.nlm.nih.gov/books/NBK554776/.

2. Drosten C., Günter S., Preiser W., van der Werf S., Brodt HR., Becker S., et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Eng. J. med. 2003. 348: 1967-76.

3. Lai C-C., Shih,T-P., Ko, W-C., Tang, H-J., Hsueh P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2010 (COVID-10).: the epidemic and the challenges. Int J Antimicrobe Agents. 55: 105924.

4. WHO Director-General’s opening remarks at the media briefing on COVID-19: 11 March 2020. www.who.int./dg/speeches/detail/who-director-general-s-opening-remarks-at-the-öedia-briefing-on -covid-19-11-march-2020.

5. Worldometer. Coronavirus/Countries. https://www.worldometers.info/ coronavirus/ countries -where-coronavirus-has-spread/. Accesed 02.07.2020.

6. Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, Liu W, Bi Y, Gao GF. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 24:490 –502. https://doi.org/10.1016/j.tim.2016.03.003.

7. Forni D, Cagliani R, Clerici M, Sironi M. Molecular evolution of human coronavirus genomes. Trends Microbiol.2017. 25:35– 48. https://doi .org/10.1016/j.tim.

8. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 17:181–192. 2019. https://doi.org/10.1038/s41579-018-0118-9.

9. Perlman S., Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nature Reviews Microbiology,2009. 7(6): 439-450.

10. Schoeman, D., Fielding, B.C. Coronavirus envelope protein: Current knowledge. Virology Journal, 2019. 16 (69): 2-22.

11. ECDC (European Centre for Diseases Prevention and Control) Rapid Risk Assessment - Severe respiratory disease associated with a novel coronavirus" , 2014.

12. ICTV Taxonomy History:Orthocoronavirinae;, July 2019.

13. de Groot, R. J., Baker, S. C., Baric, R. S., Brown, C. S., Drosten, C., Enjuanes, L., ... & Perlman, S. Commentary: Middle east respiratory syndrome coronavirus (mers-cov): announcement of the coronavirus study group. Journal of virology, 2013.87(14), 7790-7792.

14. Bedford T., Hodcroft T. "Phylogeny of SARS-like betacoronaviruses". Nextstrain. 2020. https://nextstrain.org/groups/blab/sars-like-cov.

15. Memish Z.A., Zumla, A.I., Al-Hakeem, R.F., Al-Rabeeah, A.A., et al. Family Cluster of Middle East Respiratory Syndrome Coronavirus Infections. New England Journal of Medicine,2013. 368: 2487-2494.

16. ProMed International Society for Infectious Diseases. Donate to support ProMed’s coverage of the COVID-19 outbreak. https://promedmail.org. Access date 22.06.2020.

17. Holmes, Edward C., and Andrew Rambaut. "Viral evolution and the emergence of SARS coronavirus." Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences,2004.359.1447:1059-1065.

18. Decaro, Nicola, et al. Genetic analysis of canine parvovirus type 2c. Virology, 2009, 385.1: 5-10.

19. NCBI (National Center for Biotechnology Information). Lineage Betacoronavirus. Ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=694002. Access date 23.06.2020b.

20. Van Der Hoek, Lia, et al. Identification of a new human coronavirus. Nature medicine, 2004, 10.4: 368-373.

21. WHO (World Health Organization). Coronavirus disease 2019 (COVID-19), situation report – 35. https://www.who.int/docs/default-source/coronaviruse/ situation-reports/20200224-sitrep-35-covid-19.pdf?sfvrsn1ac4218d_2. Accesed 18.06.2020c
22. Zhong, N. S., Zheng, B. J., Li, Y. M., Poon, L. L. M., Xie, Z. H., Chan, K. H., ... & Liu, X. Q. (2003). Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. The Lancet, 362(9393), 1353-1358.

23. Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus A, Fouchier R. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814 –1820. https://doi.org/10.1056/ NEJMoa1211721

24. Sutton TC., Subbarao K. Development of animal models against emerging coronavirus: from SARS to MERS coronavirus. Virology,2015. 479-480: 247-258.

25. Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., & Seed, J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicological sciences, 2007. 99(2), 366-394.

26. Rihtarič, D., Hostnik, P., Steyer, A., Grom, J., & Toplak, I. Identification of SARS-like coronaviruses in horseshoe bats (Rhinolophus hipposideros) in Slovenia. Archives of virology, 2010. 155(4), 507-514.

27. Corman, V. M., Ithete, N. L., Richards, L. R., Schoeman, M. C., Preiser, W., Drosten, C., & Drexler, J. F. Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat. Journal of virology, 2014. 88(19), 11297-11303.

28. Sabir, J. S., Lam, T. T. Y., Ahmed, M. M., Li, L., Shen, Y., Abo-Aba, S. E., ... & Alharbi, N. S. Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia. Science, 2016. 351(6268), 81-84.

29. Lau, J. T., Gu, J., Tsui, H. Y., & Wang, Z. Prevalence and associated factors of intention to participate in HIV voluntary counseling and testing for the first time among men who have sex with men in Hong Kong, China. Preventive medicine, 2013. 57(6), 813-818.

30. Wu, Z., & McGoogan, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Jama, 2020.323(13), 1239-1242.

31. Wong, A.C.P., Li,X., Lau, S.K.P., Woo, P.C.Y. Global Epidemiology of bat Coronaviruses. Viruses, 2019. 11: 174 (1-17).

32. Woo, P. C., Lau, S. K., Lam, C. S., Lau, C. C., Tsang, A. K., Lau, J. H., ... & Zheng, B. J. Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. Journal of virology, 2012. 86(7), 3995-4008.

33. De Wit, E., Van Doremalen, N., Falzarano, D., & Munster, V. J. SARS and MERS: recent insights into emerging coronaviruses. Nature Reviews Microbiology, 2016. 14(8), 523.

34. Yuen, K-S., Ye, WY., Fung, S-Y., Chan, C-P., Jin, D-Y. SARS-CoV-2 and COVID-19: The most important research questions. Cell & Bioscience,2020. 10:40.
35. WHO. WHO releases new International Classification of Diseases (ICD 11).2018. https://www.who.int/news-room/detail/18-06-2018-who-releases-new-international-classification-of-diseases-(icd-11).

36. Coronaviridae Study Group (CSB) of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, 2020. 5(4): 536-544.

37. Malik Y.S., Sircar S., Bhat S., Sharun K., Dhama K., Dadar M., et al. Emerging novel Coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments. 2020. Vet Q. 40: 68-76.

38. Lu R., ZhaoX., Li J., Niu P., Yang B., Wu H., et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 2020. 395: 565-574.

39. https://www.flickr.com/photos/niaid/49534865371/

40. https://en.wikipedia.org/wiki/Severe_acute_respiratory_syndrome_coronavirus_2#/media/File:SARS-CoV-2_without_background.png.

41. CCDC (Chinese Centre for Diseases Control and Preventation). 2020. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China, 2020. China CDC Wkly. 8: 113-122.

42. Rabenau, H. F., J. Cinatl, and H. W. Doerr. "Preliminary Pages." Prions. Vol. 11. Karger Publishers, 2004. I-XI.

43. Suchomel M, Kumdi M, Allegranzi B, Pittet D, Rotter ML. Testing of the world Health Organisation-recommended formulations for surgical hand preparation and proposals for increased efficacy. J Hosp Infect, 2011. 79: 115-118.

44. Van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., ... & Lloyd-Smith, J. O. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine, 2020. 382(16), 1564-1567.

45. Ong, S. W. X., Tan, Y. K., Chia, P. Y., Lee, T. H., Ng, O. T., Wong, M. S. Y., & Marimuthu, K. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. Jama, 2020. 323(16), 1610-1612.

46. Kratzel, A., Todt, D., V’kovski, P., Steiner, S., Gultom, M., Thao, T. T. N., ... & Dijkman, R. Inactivation of severe acute respiratory syndrome coronavirus 2 by WHO-recommended hand rub formulations and alcohols. Emerging infectious diseases, 2020. 26(7), 1592.

47. Darnell, MER., Subbarao K., Feinstone SM., Taylor DR. Inactivation of coronavirus that induces severe acute respiratory syndrome, SARS-CoV. J Virological Methods, 2004. 121: 85-91.

48. Siddharta, A., Pfaender, S., Vielle, N. J., Dijkman, R., Friesland, M., Becker, B., ... & Brill, F. H. Virucidal activity of World Health Organization–recommended formulations against enveloped viruses, including zika, ebola, and emerging coronaviruses. The Journal of infectious diseases, 2017. 215(6), 902-906.